Tebentafusp in Combination with Durvalumab And/or Tremelimumab in Patients with Metastatic Cutaneous Melanoma: a Phase 1 Study
Journal for ImmunoTherapy of Cancer(2023)
关键词
Melanoma,Immune Checkpoint Inhibitors,T-Lymphocytes,Immunotherapy
AI 理解论文
溯源树
样例

生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要